Nicolas Bertheleme

Title: Innovator Profile: Nicolas Bertheleme

Introduction

Nicolas Bertheleme is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly with his innovative work on tetrazole compounds.

Latest Patents

Bertheleme holds one patent for "Tetrazole compounds as calcium channel blockers." This patent pertains to novel tetrazole compounds, outlining processes for their preparation, pharmaceutical compositions containing these compounds, and therapeutic uses aimed at conditions where blocking the Ca2.2 calcium channels is beneficial. The described formula includes variations denoted as A, reportedly in forms (II) or (III).

Career Highlights

Nicolas is affiliated with Convergence Pharmaceuticals Limited, where he has pursued research that emphasizes the potential of tetrazole compounds in treating various medical conditions. His work underscores the importance of innovation in developing new therapeutic strategies.

Collaborations

Throughout his career, Bertheleme has collaborated with esteemed colleagues, including Paul John Beswick and Robert James Gleave. These partnerships have likely fostered an environment conducive to groundbreaking research and discovery in pharmaceuticals.

Conclusion

Nicolas Bertheleme's dedication to advancing pharmaceutical science through his patented innovation exemplifies the vital role inventors play in developing therapies that can significantly impact patient care. His contributions at Convergence Pharmaceuticals Limited and his collaboration with other researchers highlight the importance of teamwork in innovation.